Drug Approval | June 16, 2023
Briefs: Natco Pharma and Panacea Biotec
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Gabapentin Tablets are indicated for management of postherpetic neuralgia in adults
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Subscribe To Our Newsletter & Stay Updated
